What’s up with PJT’s stock price?
Since the market downfall, PJT’s share price has remained relatively flat. All other public EB’s have nosedived.
Trending Content - Investment Banking Forum
| +157 | UBS Tech layoff | 52 | 20h |
| +146 | Analyst: Why is UBS IB doing worse than peers?, UBS CFO: No Comment | 23 | 23m |
| +144 | UBS’s M&A BANKERS ARE DOING TERRIBLY. $200M EXTRA IS BEING CUT | 30 | 25m |
| +60 | Are target prospects getting dumber? | 26 | 2h |
| +58 | How do YOU manage networking requests? | 17 | 5h |
| +40 | Leaked Interview Questions to Chinese Recruiting Services | 24 | 15m |
| +37 | What Differentiates the Best Analysts as AI Improves? | 9 | 4d |
| +36 | Quitting After First 4 months | 12 | 1d |
| +34 | MBB Pay Raises | 26 | 1d |
| +33 | Cornell Club T10 Rankings (UPDATED 10/2026) | 19 | 1d |
Career Resources
RSSG is probably going to town, so it makes up for lower M&A revenue
Haha completely forgot about RX. Although, brings up the point that every EB also has a decent RX biz.
HL is the only firm that breaks Rx out in financials. If you look at MD count, would say only HL and PJT are truly restructuring focused enough to be net well positioned in this environment. Rest of the EBs have too much M&A
Would expect rx comprises a larger share of PJT’s business than it does at most other boutiques
Fee backlog + counter cyclical RX business
At facere et molestiae quibusdam dignissimos tempora. Et ratione itaque eos temporibus harum. Repellendus commodi dicta et quod quibusdam. Fugiat voluptatem consequatur aspernatur excepturi aliquam amet quisquam.
Omnis cum deleniti beatae debitis. Quaerat in voluptatum iste porro voluptates. Ratione quia architecto reiciendis voluptatem eum. Ea consequatur aut veniam ratione. Praesentium ut explicabo a cum quo ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...